Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108250236B reveals a novel ytterbium catalyst for efficient, solvent-free synthesis of alpha-hydroxy phosphates, offering significant cost and supply chain advantages.
Patent CN113511994B details a high-purity levetiracetam synthesis using chiral BINOL-derived phosphoric acid, offering superior enantioselectivity and simplified one-pot processing for pharmaceutical manufacturers.
Patent CN104276928B reveals a green synthesis route for bisphenol derivatives, offering significant cost reduction and supply chain reliability for polymer additive manufacturing.
Patent CN121135789A reveals a novel supramolecular catalytic route for chiral Ugi amine. Achieve 99% ee and 99% yield with scalable, cost-effective manufacturing for global supply chains.
Discover a scalable synthesis route for chiral binaphthalene dicarboxylic acid via patent CN101781197A. Achieve >99% optical purity and significant cost reduction in pharma intermediate manufacturing.
Novel synthetic route for IMPD reference standard offering higher yield and safer conditions for pharmaceutical quality control supply chains globally.
Patent CN101848905A details a novel enantioselective route for (S)-pregabalin using D-mannitol, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN1033521A reveals a safer route to Famotidine intermediates using bicyclic amidine salts, eliminating toxic hydrogen sulfide and improving supply chain reliability for pharmaceutical manufacturers.
Patent CN1839127A details a cost-effective NaOCl oxidation process for PPIs like Pantoprazole, minimizing sulfone impurities and ensuring high purity for commercial scale-up.
Patent CN1774430A details a novel sulfolane-based cyclopropanation for taxane intermediates, offering improved purity and scalable manufacturing for API production.
Patent CN114591185B introduces a green iridium-catalyzed method for amino alcohol synthesis using ethylene glycol, offering high selectivity and supply chain advantages.
Patent CN1568304A reveals a catalytic hydrogenation process for cyclopropylalanine derivatives, ensuring high purity and cost-effective supply chain solutions for global pharmaceutical manufacturers.
Patent CN103145584A details a novel route for (3R,5R)-3,5-dihydroxy-6-cyanohexanoate, offering high stereoselectivity and avoiding toxic cyanides for reliable pharmaceutical intermediate supply.
Patent CN115057895A reveals a faster Z-erythromycin oxime process reducing production cycles and enhancing supply chain reliability for veterinary pharmaceutical manufacturers.
Patent CN114214375A details a novel enzymatic route for high-purity Ruxolitinib intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel Friedel-Crafts route for UV absorber intermediates ensures high purity and scalable production. Optimize supply chain stability and manufacturing costs effectively.
Discover the advanced Negishi coupling process for 5-(1,3-oxazol-2-yl)benzoic acid derivatives. Enhanced yields and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN102070529A details a robust synthesis for axially chiral imidazolium salts. Discover cost-effective production of stable NHC precursors for asymmetric catalysis.
Novel solid-base catalysis method for 16a-hydroxy prednisonlone production. Reduces impurities and cost. Reliable supply chain for budesonide manufacturing intermediates.
Patent CN1160350C details a rhodium-catalyzed route for high-purity chiral lactones, offering significant cost reduction in API manufacturing and reliable supply chain continuity.